Remdesivir ACTT-1: Adaptive COVID-19 Treatment Trial Part 1
Background: The saga of Remdesivir for treatment of COVID-19 continues. We previously covered two studies of this drug on REBEL EM (Link is HERE & Link is HERE). One trial...
Marco Torres |
Welcome to our store!
New collections added on a weekly basis!
Now Accepting FSA & HSA cards
for all orders over $99.99 within the CONTINENTAL USA.
Background: The saga of Remdesivir for treatment of COVID-19 continues. We previously covered two studies of this drug on REBEL EM (Link is HERE & Link is HERE). One trial...
Marco Torres |
This publication has now been retracted by Lancet (June 4, 2020) Background: There is no conclusive evidence that chloroquine, or its derivative hydroxychloroquine, with or without a second-generation macrolide is...
Marco Torres |
Disclaimer: This post explores some of the pathophysiologic findings in severe SARS-CoV-2 infection. It explores possible mechanisms-based and posits theories BUT, this is not a clinical post. The hypothesis and...
Marco Torres |
While the rate of prepublications on COVID19 continue to be cranked out, we at REBEL EM have reduced our blog post production. It’s not because we’re reading less, but we’ve...
Marco Torres |
There is a lot we still do not know when it comes to COVID-19 pathophysiology. We are learning every day, and as we navigate the waters of the unknown, there...
Marco Torres |
Background: Current management of COVID-19 focuses on supportive care as there are yet to be robust, data driven treatments. To date, there has barely been a glimmer of hope based...
Marco Torres |
Background: Although Helmet CPAP is not something commonly used in the US, I think its nice to know what other potential options there are to help patients in the midst of...
Marco Torres |
There continues to be a slew of publications coming out on a near daily basis in regard to COVID-19. Some publications will deserve their own posts and others can really...
Marco Torres |
Introduction: Emergency physicians rarely are involved in tube exchanges; I can’t remember the last time I had to do one. However, during the COVID19 surge, we found ourselves boarding intubated...
Marco Torres |
The Novel Coronavirus 2019, was first reported on in Wuhan, China in late December 2019. The outbreak was declared a public health emergency of international concern in January 2020 and...
Marco Torres |
Background: Over the past few weeks there has been a shift in the management of critically ill COVID-19 patients. Many seem to have moved away from an intubate early strategy...
Marco Torres |
Background: Currently, there are no approved medications for the treatment of COVID-19, but, there are many investigational agents that have shown antiviral activity against SARS-CoV-2 in vitro. Unfortunately in vitro...
Marco Torres |
Needs Assessment: As the COVID19 pandemic continues to mount, hospitals will rapidly reach maximal capacity. As a result, patients are boarding longer in the ED and, new patients are waiting...
Marco Torres |
Your cart
Visit our support center
Expert help & advice
Check your order status
Updates & tracking
Returns & exchanges
All you need to know
Everyday Low Prices
No need to wait for a "sale"
Choose options